Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationClin. Exp. Immunol. 1993, 94(2):286-90
AbstractThe usefulness of several different methods for detecting immune complex formation and complement activation in the circulation were applied to samples from patients receiving intravenous Streptokinase therapy for myocardial infarction. Streptokinase is a foreign antigen and can cause immune reactions. We collected samples from 13 patients, before Streptokinase administration (baseline), at the end of infusion (1 h), 12 h later and on day 7. We measured IgG containing immune complexes (IgG-IC), free C3d and antibodies to Streptokinase by ELISA, and CR1, C3d and C4d on erythrocytes by flow cytometric assay. Antibodies to Streptokinase are common, as all but two of the patients had measurable antibody levels. During Streptokinase treatment there was a drop in antibody levels, most prominent in those patients who had high baseline levels. At the same time increased levels of free C3d and erythrocyte-bound C3d were observed. After 12 h free C3d was usually back to baseline level, but C3d on erythrocytes was still raised. These data indicate the formation of Streptokinase immune complexes in patients with high Streptokinase antibody levels, and show that these complexes are cleared rapidly from the circulation, leaving more persistent signs of complement activation. We conclude that free C3d is a good indicator of ongoing complement activation, whereas C3d on erythrocytes indicates that complement activation has recently taken place.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Complement activation reaches maximum during equilibrium between antigen and antibody in an in vitro model for thrombolysis with streptokinase.
- Authors: Leinøe E, Pachaï A, Brandslund I
- Issue date: 2000 Oct
- A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
- Authors: Freysdottir J, Sigfusson A
- Issue date: 1991 Aug 28
- Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
- Authors: Aguado MT, Lambris JD, Tsokos GC, Burger R, Bitter-Suermann D, Tamerius JD, Dixon FJ, Theofilopoulos AN
- Issue date: 1985 Oct
- Why do patients develop reactions to streptokinase?
- Authors: Lynch M, Pentecost BL, Littler WA, Stockley RA
- Issue date: 1993 Nov
- Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
- Authors: Makinde VA, Senaldi G, Jawad AS, Berry H, Vergani D
- Issue date: 1989 Apr